title: Subfornical organ differentially modulates baroreflex function in normotensive and two-kidney, one-clip hypertensive rats.
abstract: During activation of the renin-angiotensin system, hindbrain circumventricular organs such as the area postrema have been implicated in modulating the arterial baroreflex. This study was undertaken to test the hypothesis that the subfornical organ (SFO), a forebrain circumventricular structure, may also modulate the baroreflex. Studies were performed in rats with two-kidney, one-clip (2K,1C) hypertension as a model of endogenously activated renin-angiotensin system. Baroreflex function was ascertained during ramp infusions of phenylephrine and nitroprusside in conscious sham-clipped and 5-wk 2K,1C rats with either a sham or electrolytically lesioned SFO. Lesioning significantly decreased mean arterial pressure in 2K,1C rats from 158 +/- 7 to 131 +/- 4 mmHg but not in sham-clipped rats. SFO-lesioned, sham-clipped rats had a significantly higher upper plateau and range of the renal sympathetic nerve activity-mean arterial pressure relationship compared with sham-clipped rats with SFO ablation. In contrast, lesioning the SFO in 2K,1C rats significantly decreased both the upper plateau and range of the baroreflex control of renal sympathetic nerve activity, but only the range of the baroreflex response of heart rate decreased. Thus, during unloading of the baroreceptors, the SFO differentially modulates the baroreflex responses in sham-clipped vs. 2K,1C rats. Since lesioning the SFO did not influence plasma angiotensin II (ANG II), the effects of the SFO lesion are not caused by changes in circulating levels of ANG II. These findings support a pivotal role for the SFO in the sympathoexcitation observed in renovascular hypertension and in baroreflex regulation of sympathetic activity in both normal and hypertensive states.
authors.affiliation: Dept. of Internal Medicine, Wayne State Univ. School of Medicine, 4160 John R. St., Detroit, MI 48201, USA.
authors.forename: Maria
authors.initials: M
authors.lastname: Maliszewska-Scislo
authors.forename: Haiping
authors.initials: H
authors.lastname: Chen
authors.forename: Robert A
authors.initials: RA
authors.lastname: Augustyniak
authors.forename: Dale
authors.initials: D
authors.lastname: Seth
authors.forename: Noreen F
authors.initials: NF
authors.lastname: Rossi
mesh_terms: D000804:Angiotensin II / Q000097:blood; D000818:Animals; D017704:Baroreflex / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D003714:Denervation; D004195:Disease Models, Animal; D006339:Heart Rate / Q000502:physiology; D006977:Hypertension, Renal / Q000503:physiopathology*; D007668:Kidney / Q000294:innervation* / Q000502:physiology*; D008297:Male; D009599:Nitroprusside / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013356:Subfornical Organ / Q000502:physiology*; D013525:Surgical Instruments; D013564:Sympathetic Nervous System / Q000502:physiology; D013566:Sympathomimetics / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014882:Water-Electrolyte Balance / Q000502:physiology
chemical_list: D013566:Sympathomimetics; D014665:Vasodilator Agents; D000804:Angiotensin II; D009599:Nitroprusside; D010656:Phenylephrine
references.citation: J Auton Nerv Syst. 1995 Oct 5;55(1-2):92-104
references.pmid: 8690857
references.citation: Am J Physiol. 1981 Sep;241(3):H381-8
references.pmid: 7282947
references.citation: J Physiol. 1993 Feb;461:501-11
references.pmid: 8350273
references.citation: Brain Res. 1989 Mar 27;483(1):192-5
references.pmid: 2706508
references.citation: Brain Res. 1998 Aug 10;801(1-2):239-43
references.pmid: 9729407
references.citation: Circ Res. 1990 Dec;67(6):1462-73
references.pmid: 2245506
references.citation: Brain Res. 2004 Jan 2;995(1):109-17
references.pmid: 14644476
references.citation: Exp Brain Res. 1986;62(3):509-14
references.pmid: 3720882
references.citation: Am J Physiol. 1980 Nov;239(5):R382-9
references.pmid: 7435651
references.citation: Neurosci Lett. 2004 Oct 7;369(1):14-8
references.pmid: 15380299
references.citation: Circ Res. 1984 Apr;54(4):355-66
references.pmid: 6370491
references.citation: Circ Res. 1983 Aug;53(2):223-34
references.pmid: 6883646
references.citation: Circ Res. 2003 Jun 27;92(12):1330-6
references.pmid: 12764023
references.citation: Clin Exp Pharmacol Physiol. 1997 Jan;24(1):96-101
references.pmid: 9043813
references.citation: Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1592-602
references.pmid: 11959620
references.citation: Am J Physiol. 1988 Dec;255(6 Pt 2):R961-7
references.pmid: 3202228
references.citation: Fed Proc. 1984 Jan;43(1):25-31
references.pmid: 6360715
references.citation: Hypertension. 1991 May;17(5):626-35
references.pmid: 2022407
references.citation: Am J Physiol. 1998 Nov;275(5):R1523-9
references.pmid: 9791069
references.citation: J Neuroendocrinol. 2004 Apr;16(4):340-7
references.pmid: 15089972
references.citation: Biol Signals. 1995 May-Jun;4(3):117-23
references.pmid: 8750937
references.citation: Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1601-11
references.pmid: 12521945
references.citation: J Hypertens Suppl. 1986 Dec;4(5):S27-30
references.pmid: 3471907
references.citation: Am J Physiol Renal Physiol. 2007 Jul;293(1):F139-47
references.pmid: 17376762
references.citation: Am J Physiol. 1993 May;264(5 Pt 2):F891-8
references.pmid: 8388654
references.citation: J Pharmacol Exp Ther. 1994 Nov;271(2):804-10
references.pmid: 7965799
references.citation: Am J Physiol. 1993 Oct;265(4 Pt 2):H1275-82
references.pmid: 8238414
references.citation: Front Neuroendocrinol. 1997 Oct;18(4):383-439
references.pmid: 9344632
references.citation: Acta Physiol Scand Suppl. 1990;591:100-6
references.pmid: 2220402
references.citation: Am J Physiol. 1984 May;246(5 Pt 2):F620-6
references.pmid: 6372522
references.citation: Auton Neurosci. 2002 Jan 10;95(1-2):131-6
references.pmid: 11871778
references.citation: Hypertension. 2003 Dec;42(6):1124-9
references.pmid: 14597646
references.citation: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1804-12
references.pmid: 11009467
references.citation: Proc Natl Acad Sci U S A. 1984 Mar;81(5):1575-9
references.pmid: 6324205
references.citation: Am J Physiol. 1988 May;254(5 Pt 2):R746-54
references.pmid: 3364604
references.citation: Am J Physiol. 1999 Jul;277(1 Pt 2):R56-65
references.pmid: 10409258
references.citation: Hypertension. 1987 Apr;9(4):355-61
references.pmid: 3557601
references.citation: Kidney Int. 1986 Sep;30(3):437-52
references.pmid: 3537449
references.citation: Am J Physiol. 1998 Jul;275(1):R46-55
references.pmid: 9688959
references.citation: Hypertension. 1998 Jan;31(1):68-72
references.pmid: 9449393
references.citation: Am J Physiol. 1995 Mar;268(3 Pt 2):R625-33
references.pmid: 7900904
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Dec;287(6):R1325-34
references.pmid: 15308489
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R856-62
references.pmid: 15793039
references.citation: Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H680-5
references.pmid: 15458953
references.citation: Am J Physiol. 1986 Jun;250(6 Pt 2):R960-72
references.pmid: 3521337
references.citation: Appetite. 1998 Dec;31(3):309-31
references.pmid: 9920685
references.citation: Hypertension. 2003 Mar;41(3):576-82
references.pmid: 12623962
references.citation: J Cardiovasc Pharmacol. 1995;26 Suppl 2:S7-16
references.pmid: 8642810
references.citation: Neuroendocrinology. 1980 Dec;31(6):380-4
references.pmid: 7453950